These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 22251259

  • 1. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
    van Rosmalen J, de Kok IM, van Ballegooijen M.
    BJOG; 2012 May; 119(6):699-709. PubMed ID: 22251259
    [Abstract] [Full Text] [Related]

  • 2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson BG, Hagmar B, Johansson B, Rylander E, Dillner J.
    J Natl Cancer Inst; 2009 Jan 21; 101(2):88-99. PubMed ID: 19141778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.
    Goldhaber-Fiebert JD, Stout NK, Salomon JA, Kuntz KM, Goldie SJ.
    J Natl Cancer Inst; 2008 Mar 05; 100(5):308-20. PubMed ID: 18314477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa.
    Vijayaraghavan A, Efrusy M, Lindeque G, Dreyer G, Santas C.
    Gynecol Oncol; 2009 Feb 05; 112(2):377-83. PubMed ID: 19081611
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.
    Burger EA, Ortendahl JD, Sy S, Kristiansen IS, Kim JJ.
    Br J Cancer; 2012 Apr 24; 106(9):1571-8. PubMed ID: 22441643
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology.
    Termrungruanglert W, Khemapech N, Tantitamit T, Havanond P.
    J Gynecol Oncol; 2019 Mar 24; 30(2):e17. PubMed ID: 30740950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.